In our cohort, however, the decline of circulating irisin from PreDM to T2DM, together with its weak association with insulin resistance indices, points toward reduced myokine production rather than compensatory hypersecretion—potentially reflecting impaired PGC-1α activation and skeletal muscle mitochondrial dysfunction. The gene discussed is FNDC5; the disease is Insulin resistance.